Advertisement

Topics

Deals and M&As this week: Alliance Pharma, Bayer, Onxeo

19:00 EDT 21 Jun 2018 | Pharmaceutical Technology

Alliance Pharma plans to acquire exclusive distribution rights to Nizoral, an anti-dandruff brand, from Janssen Pharmaceutica NV for £60m ($79.5m). Alliance...
Read More...

The post Deals and M&As this week: Alliance Pharma, Bayer, Onxeo appeared first on Pharmaceutical Technology.

Original Article: Deals and M&As this week: Alliance Pharma, Bayer, Onxeo

NEXT ARTICLE

More From BioPortfolio on "Deals and M&As this week: Alliance Pharma, Bayer, Onxeo"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...